1COV.F1COV.FFSX
Loading
EBITDA Over TimeContracting
Percentile Rank0
3Y CAGR-28.9%
5Y CAGR-22.0%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-28.9%/yr
vs -21.7%/yr prior
5Y CAGR
-22.0%/yr
Recent deceleration
Acceleration
-7.2pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.3x
Contraction
Streak
4 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$426.00M-61.8%
2024$1.12B-1.8%
2023$1.14B-4.1%
2022$1.18B-61.3%
2021$3.06B+107.0%
2020$1.48B-5.1%
2019$1.56B-50.6%
2018$3.15B-6.4%
2017$3.37B+78.4%
2016$1.89B-